1-20 of 96
Katie Robinson
Close
Sort by
News

Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM

Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Clonal Hematopoiesis Associated With Cytopenias After CAR-T Therapy for MM
News

Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

Katie Robinson
Published: 2025
Abstract
March 2025
View News titled, Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia
News

Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T

Katie Robinson
Published: 2025
Abstract
March 2025
View News titled, Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T
News

Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care

Katie Robinson
Published: 2025
Abstract
April 2025
View News titled, Study of LBCL Confirms Prognostic Value of ctDNA in Second-Line Liso-Cel Versus Standard of Care
News

Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM
News

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study
News

Cilta-Cel Achieves Rapid, Sustained MRD Negativity in Lenalidomide-Refractory MM as Early as First Relapse

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Cilta-Cel Achieves Rapid, Sustained MRD Negativity in Lenalidomide-Refractory MM as Early as First Relapse
News

Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms
News

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP
News

Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH
News

Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis
News

EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues
News

Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Plus Lenalidomide Shows MRD, PFS Benefit in Newly Diagnosed MM After AHCT in Clinically Relevant Subgroups
News

More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma

Katie Robinson
Published: 2024
Abstract
December 2024
View News titled, More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma
News

Teclistamab-Based Induction Regimens Achieve MRD Negativity in Patients With Transplant-Eligible NDMM

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Teclistamab-Based Induction Regimens Achieve MRD Negativity in Patients With Transplant-Eligible NDMM
News

Study Validates SCD Biomarker for Targeted P-Selectin Therapy Response

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Study Validates SCD Biomarker for Targeted P-Selectin Therapy Response
News

Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category
News

Pirtobrutinib Shows Efficacy in Previously Treated Richter Transformation

Katie Robinson
Published: 2024
Abstract
Mid-November 2024
View News titled, Pirtobrutinib Shows Efficacy in Previously Treated Richter Transformation
News

Studying the Foundations of Aging in Hematologic Disease

Katie Robinson
Published: 2024
Abstract
Mid-November 2024
View News titled, Studying the Foundations of Aging in Hematologic Disease
News

Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma

Katie Robinson
Published: 2024
Abstract
November 2024
View News titled, Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma